Phibro Animal Health Share Price (NASDAQ: PAHC)

$37.05

▲

-1.41

(-3.67%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Phibro Animal Health Stock chart to analyse performance

Phibro Animal Health stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$36.45
Today's High:$38.06
$37.05
1.62%
Downside
Day's Volatility :4.23%
Upside
2.65%
52 Weeks Low:$16.16
52 Weeks High:$38.83
$37.05
56.38%
Downside
52 Weeks Volatility :58.38%
Upside
4.58%

Phibro Animal Health Stock Returns

Period	Phibro Animal Health Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	50.77%	3.6%	0.0%
6 Months	51.14%	-7.7%	0.0%
1 Year	86.51%	-12.6%	0.0%
3 Years	142.22%	9.5%	-4.7%

Phibro Animal Health Corp Key Stats

Check Phibro Animal Health key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$38.46
Open	$37.71
Today's High	$38.06
Today's Low	$36.45
Market Capitalization	$1.6B
Today's Volume	$645.0K
52 Week High	$38.83
52 Week Low	$16.16
Revenue TTM	$1.3B
EBITDA	$156.1M
Earnings Per Share (EPS)	$1.15
PE Ratio	32.23
Dividend Yield	0.0%
Profit Margin	3.72%
Quarterly Earnings Growth YOY	21.91%
Return On Equity TTM	17.8%

Stock Returns calculator for Phibro Animal Health Stock including INR - Dollar returns

The Phibro Animal Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Phibro Animal Health investment value today

Current value as on today

₹1,91,746

Returns

₹91,746

(+91.75%)

Returns from Phibro Animal Health Stock

₹86,462 (+86.46%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Phibro Animal Health Stock

-70%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Phibro Animal Health Stock from India on INDmoney has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Phibro Animal Health Corp

Name
Holdings %
Name
Holdings %
BlackRock Inc
9.11%
Vanguard Group Inc
3.82%
State Street Corp
2.27%
Acadian Asset Management LLC
1.93%
Pzena Investment Management, LLC
1.79%
Renaissance Technologies Corp
1.74%

Analyst Recommendation on Phibro Animal Health Stock

Rating

Trend

Sell

0%Buy

33%Hold

66%Sell

Based on 9 Wall street analysts offering stock ratings for Phibro Animal Health(by analysts ranked 0 to 5 stars)

Phibro Animal Health Share Price Target

What analysts predicted

Downside of 12.28%

Target:

$32.50

Current:

$37.05

Phibro Animal Health share price target is $32.50, a slight Downside of 12.28% compared to current price of $37.05 as per analysts' prediction.

Phibro Animal Health Stock Insights

Price Movement
In the last 7 days, PAHC stock has moved up by 14.2%
Increasing Revenue
Revenue is up for the last 4 quarters, 260.43M → 378.69M (in $), with an average increase of 11.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 20.88M → 17.22M (in $), with an average decrease of 17.5% per quarter

Phibro Animal Health Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Revenue	$800.4M	↓ 3.33%
Net Income	$33.6M	↓ 38.66%
Net Profit Margin	4.19%	↓ 2.42%

	FY21	Y/Y Change
Revenue	$833.4M	↑ 4.12%
Net Income	$54.4M	↑ 62.09%
Net Profit Margin	6.53%	↑ 2.34%

	FY22	Y/Y Change
Revenue	$942.3M	↑ 13.07%
Net Income	$49.2M	↓ 9.58%
Net Profit Margin	5.22%	↓ 1.31%

	FY23	Y/Y Change
Revenue	$977.9M	↑ 3.78%
Net Income	$32.6M	↓ 33.69%
Net Profit Margin	3.33%	↓ 1.89%

	FY24	Y/Y Change
Revenue	$1.0B	↑ 4.07%
Net Income	$2.4M	↓ 92.59%
Net Profit Margin	0.24%	↓ 3.09%

	FY25	Y/Y Change
Revenue	$1.3B	↑ 27.37%
Net Income	$48.3M	↑ 1897.68%
Net Profit Margin	3.72%	↑ 3.48%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$263.2M	↑ 5.31%
Net Income	$8.4M	↑ 559.73%
Net Profit Margin	3.19%	↑ 2.68%

	Q2 FY24	Q/Q Change
Revenue	$273.2M	↑ 3.78%
Net Income	$752.0K	↓ 91.05%
Net Profit Margin	0.28%	↓ 2.91%

	Q3 FY24	Q/Q Change
Revenue	$260.4M	↓ 4.66%
Net Income	$7.0M	↑ 827.53%
Net Profit Margin	2.68%	↑ 2.4%

	Q4 FY24	Q/Q Change
Revenue	$309.3M	↑ 18.75%
Net Income	$3.2M	↓ 54.34%
Net Profit Margin	1.03%	↓ 1.65%

	Q1 FY25	Q/Q Change
Revenue	$347.8M	↑ 12.47%
Net Income	$20.9M	↑ 555.57%
Net Profit Margin	6.0%	↑ 4.97%

	Q2 FY25	Q/Q Change
Revenue	$378.7M	↑ 8.88%
Net Income	$17.2M	↓ 17.51%
Net Profit Margin	4.55%	↓ 1.45%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Profit	$256.9M	↓ 2.91%

	FY21	Y/Y Change
Profit	$271.4M	↑ 5.64%

	FY22	Y/Y Change
Profit	$285.4M	↑ 5.17%

	FY23	Y/Y Change
Profit	$298.2M	↑ 4.5%

	FY24	Y/Y Change
Profit	$313.1M	↑ 4.98%

	FY25	Y/Y Change
Profit	$399.9M	↑ 27.74%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$78.9M	↑ 0.33%

	Q2 FY24	Q/Q Change
Profit	$86.8M	↑ 10.02%

	Q3 FY24	Q/Q Change
Profit	$83.5M	↓ 3.78%

	Q4 FY24	Q/Q Change
Profit	$101.9M	↑ 22.01%

	Q1 FY25	Q/Q Change
Profit	$104.6M	↑ 2.65%

	Q2 FY25	Q/Q Change
Profit	$110.0M	↑ 5.2%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Operating Cash Flow	$59.3M	↑ 25.82%
Investing Cash Flow	$-120.4M	↑ 751.84%
Financing Cash Flow	$40.9M	↓ 1096.74%

	FY21	Y/Y Change
Operating Cash Flow	$48.3M	↓ 18.61%
Investing Cash Flow	$-18.6M	↓ 84.57%
Financing Cash Flow	$-17.0M	↓ 141.52%

	FY22	Y/Y Change
Operating Cash Flow	$31.6M	↓ 34.48%
Investing Cash Flow	$-22.6M	↑ 21.54%
Financing Cash Flow	$16.3M	↓ 196.16%

	FY23	Y/Y Change
Operating Cash Flow	$13.3M	↓ 57.94%
Investing Cash Flow	$-74.0M	↑ 227.77%
Financing Cash Flow	$27.0M	↑ 65.13%

	FY24	Y/Y Change
Operating Cash Flow	$87.6M	↑ 558.11%
Investing Cash Flow	$-48.2M	↓ 34.89%
Financing Cash Flow	$-6.8M	↓ 125.08%

	FY25	Y/Y Change
Operating Cash Flow	$80.1M	↓ 8.53%
Investing Cash Flow	$-288.7M	↑ 499.01%
Financing Cash Flow	$207.1M	↓ 3160.49%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$11.4M	↓ 63.85%
Investing Cash Flow	$1.1M	↓ 104.55%
Financing Cash Flow	$4.9M	↓ 133.01%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$28.4M	↑ 149.2%
Investing Cash Flow	$-9.1M	↓ 906.28%
Financing Cash Flow	$1.8M	↓ 63.19%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$12.6M	↓ 55.6%
Investing Cash Flow	$-2.9M	↓ 67.84%
Financing Cash Flow	$-29.2M	↓ 1733.86%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$3.1M	↓ 75.63%
Investing Cash Flow	$-260.5M	↑ 8789.86%
Financing Cash Flow	$276.3M	↓ 1046.4%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$43.2M	↑ 1302.93%
Investing Cash Flow	$-18.3M	↓ 92.99%
Financing Cash Flow	$-32.2M	↓ 111.66%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$21.3M	↓ 50.71%
Investing Cash Flow	$-7.0M	↓ 61.46%
Financing Cash Flow	$-7.8M	↓ 75.9%

Phibro Animal Health Technicals Summary

Sell

Neutral

Buy

Phibro Animal Health is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Phibro Animal Health Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Phibro Animal Health Corp	41.94%	51.14%	86.51%	142.22%	79.82%
Haleon Plc Spon Ads	1.5%	-7.33%	-3.49%	69.05%	32.32%
United Therapeutics Corporation	3.57%	-1.69%	-13.51%	34.83%	71.41%
Zoetis Inc.	6.13%	-8.28%	-14.8%	-1.88%	-3.48%
Neurocrine Biosciences Inc.	8.29%	21.94%	11.59%	32.16%	20.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Phibro Animal Health Corp	32.23	32.23	1.66	2.03	0.18	0.06	0.0	7.05
Haleon Plc Spon Ads	21.53	21.53	3.14	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	11.9	11.9	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.97	26.97	2.53	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	41.3	41.3	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Phibro Animal Health Corp	Sell	$1.6B	79.82%	32.23	3.72%
Haleon Plc Spon Ads	Buy	$43.4B	32.32%	21.53	13.81%
United Therapeutics Corporation	Buy	$13.8B	71.41%	11.9	40.36%
Zoetis Inc.	Buy	$69.3B	-3.48%	26.97	27.83%
Neurocrine Biosciences Inc.	Buy	$13.8B	20.59%	41.3	13.88%

About Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Organization	Phibro Animal Health
Employees	1940
CEO	Mr. Jack Clifford Bendheim
Industry	Health Technology

Key Management of Phibro Animal Health Corp

Name	Title
Mr. Jack Clifford Bendheim	Chairman, President & CEO
Mr. Glenn C. David	Chief Financial Officer
Mr. Larry L. Miller	Chief Operating Officer
Mr. Daniel M. Bendheim J.D.	Executive VP of Corporate Strategy & Director
Mr. Jonathan Bendheim	Executive Vice President of Global Technology & People and Director
Ms. Judith A. Weinstein	Senior VP, General Counsel & Corporate Secretary
Ms. Lisa A. Escudero	Senior Vice President of Human Resources
Mr. Ramon Fuenmayor	President South America Region
Mr. Samson Li	President of Asia Pacific Region
Mr. Todd Armstrong	President of North American Region

Important FAQs about investing in PAHC Stock from India :

What is Phibro Animal Health share price today?

Phibro Animal Health share price today is $37.05 as on August 30, 2025 at 1:29 am IST at the close of the market. Phibro Animal Health share today touched a day high of $38.06 and a low of $36.45.

What is the 52 week high and 52 week low for Phibro Animal Health share?

Phibro Animal Health share touched a 52 week high of $38.83 and a 52 week low of $16.16. Phibro Animal Health stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $37.05, lower by 4.58% versus the 52 week high.

How to invest in Phibro Animal Health Stock (PAHC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Phibro Animal Health on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Phibro Animal Health Shares that will get you 0.0405 shares as per Phibro Animal Health share price of $37.05 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Phibro Animal Health Stock (PAHC) from India?

Indian investors can start investing in Phibro Animal Health (PAHC) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Phibro Animal Health stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Phibro Animal Health share’s latest price of $37.05 as on August 30, 2025 at 1:29 am IST, you will get 0.2699 shares of Phibro Animal Health. Learn more about fractional shares .

What are the returns that Phibro Animal Health has given to Indian investors in the last 5 years?

Phibro Animal Health stock has given 79.82% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?